FDA clears Radialis PET imager

2022 07 18 18 48 3323 2022 07 18 Radialis 400

The U.S. Food and Drug Administration (FDA) has cleared Radialis' PET Imager, a small footprint, organ-targeted device.

The Radialis PET Imager. Image courtesy of Radialis.The Radialis PET Imager. Image courtesy of Radialis.

The system offers high spatial resolution and consists of a small field-of-view camera developed for close-range imaging, according to the firm. It features a partial-ring planar PET camera fitted with lutetium-based gamma-ray detectors that collect gamma rays emitted by radiopharmaceuticals injected into patients, the company said.

The technology is based on research that was conducted at Lakehead University in Thunder Bay, Ontario, Canada.

Page 1 of 594
Next Page